← All insights
HERMS · INSIGHTS

The Emirates Drug Establishment: What Changes for Pharmaceutical Companies in the UAE

The UAE has consolidated pharmaceutical regulation under one federal body. According to the EDE, it was established on 29 September 2023 and is the federal authority responsible for regulating medical and pharmaceutical products, including medical devices, blood derivatives, stem cells, medicated cosmetics and veterinary medicines.

Discover the HERMS life sciences platform and our regulatory affairs expertise.

What this means in practice

Single federal regulator: marketing authorisations, establishment licensing and pharmacovigilance services sit with EDE, taking over functions previously handled by MOHAP.

Digital-first services: EDE services are accessed online, with UAE PASS used for authentication on several services.

Marketing authorisation validity: EDE's service page states that marketing authorisation certificates are issued for five years or for the validity it grants.

Pharmacovigilance officers: Marketing Authorisation Holders apply to EDE to approve and register their Qualified Person for Pharmacovigilance (QPPV).

What companies should do now

Confirm that company, manufacturer and product records are correctly reflected under EDE.

Review renewal dates and variation plans against current EDE procedures.

Verify the status of your local QPPV and pharmacovigilance system documentation.

Monitor EDE legislation and guideline updates, which are published on its portal.

How HERMS supports

HERMS acts as a regulatory partner for companies entering or operating in the UAE: company and manufacturer registration, dossier preparation, submission management, renewals and variations, and pharmacovigilance support.

HERMS provides consultancy and advisory support to pharmaceutical and healthcare companies across regulatory affairs, market access and commercial development. We help businesses assess opportunities, navigate requirements and make informed decisions.

Unsure how the EDE transition affects your portfolio? Request a portfolio status review from HERMS. Contact HERMS →

References

EDE – About Us: https://www.ede.gov.ae/en/home

EDE – Issuance of Marketing Authorization: https://www.ede.gov.ae/en/w/issuance-of-marketing-authorization-for-a-drug-or-biopharmaceutical-product

EDE – Approval of the Pharmacovigilance Officer: https://www.ede.gov.ae/nl/w/approval-of-pharmacovigilance-officer-within-uae

Related: drug registration in the UAE: regulatory roadmap for manufacturers.

HERMS supports registration dossier preparation and pharmacovigilance activities for pharmaceutical and healthcare companies. Our services help businesses prepare regulatory documentation and address product safety requirements.

FOR TECHNICAL ENQUIRIES,
CALL +971505528088

For HCPs

For patients

For researchers

ENGINEERING INTELLIGENCE. REVOLUTIONIZING LIFE SCIENCES.

HERMS is the intelligence platform. Its applications are the decision engines. HERMS expert services support implementation and regulated execution of the HERMS intelligence ecosystem, from regulatory and market access to pharmacovigilance, compliance and quality.

Drug registration timelines by country · SFDA, MOHAP, EDE, EDA, EMA and FDA timelines · GCC central registration